Fig. 3From: CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathwayThe overall survival among 13 genes in pancreatic cancer patients. A–M Majority of the selected genes are related to the longer survival of pancreatic cancer patients in the TCGA database. CHRNB2 showed the lowest hazard ratio (0.5) and P value (< 0.001) among the 13 genesBack to article page